Medicare Enrolled

Dr. Amanda Doyle, M.D.

Dermatology · Brooklyn, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
450 CLARKSON AVE, Brooklyn, NY 11203
7182708867
Registered in NPPES since 2011
NPI: 1497049548 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Doyle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doyle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Doyle

Dr. Amanda Doyle is a dermatology specialist in Brooklyn, NY, with 15 years of NPI registration. Based on federal Medicare data, Dr. Doyle performed 159 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Doyle received a total of $156,815 from 43 pharmaceutical and/or device companies across 701 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Doyle is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration ▲ 159 Medicare services $156,815 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
159
Medicare services
Bottom 10% in NY for dermatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
46 $71 $400
Skin biopsy, tangential
A procedure to remove a sample of the first identified skin growth for laboratory examination.
35 $91 $301
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $48 $300
Destruction of precancerous skin growth, 1
Removal of a single precancerous skin growth. This procedure destroys abnormal skin cells to prevent them from developing into cancer.
21 $52 $350
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
18 $100 $700
Additional skin growth biopsy
Removal of a sample of an additional skin growth for laboratory examination. This code is used for each extra lesion biopsied during the same session.
13 $47 $146
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$156,815
Total received (2018-2024)
Avg $22,402/year across 7 years
Top 5% in NY for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
701
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,045
2023
$4,235
2022
$17,606
2021
$7,471
2020
$16,426
2019
$27,474
2018
$80,557

Payments by company (2024)

MERZ NORTH AMERICA, INC.
$1,348
ABBVIE INC.
$857
Incyte Corporation
$135
Amgen Inc.
$127
PFIZER INC.
$125
Galderma Laboratories, L.P.
$98
GENZYME CORPORATION
$69
LEO Pharma Inc.
$63
Lilly USA, LLC
$58
Ortho Dermatologics, a division of Bausch Health US, LLC
$51
Abbott Laboratories
$27
Dermavant Sciences, Inc.
$25
Regeneron Healthcare Solutions, Inc.
$24
SUN PHARMACEUTICAL INDUSTRIES INC.
$19
Arcutis Biotherapeutics, Inc.
$18
Top 3 companies account for 76.8% of 2024 payments
All-time payments by company (2018-2024) ›
Merz North America, Inc.
$110,805
MERZ NORTH AMERICA, INC.
$22,452
Allergan, Inc.
$11,450
Galderma Laboratories, L.P.
$1,923
Ortho Dermatologics, a division of Bausch Health US, LLC
$1,068
ABBVIE INC.
$998
AbbVie Inc.
$893
LEO Pharma Inc.
$618
Biofrontera Inc.
$576
Incyte Corporation
$558
Almirall LLC
$543
Allergan Inc.
$540
PFIZER INC.
$519
GENZYME CORPORATION
$499
AbbVie, Inc.
$458
Amgen Inc.
$392
Regeneron Healthcare Solutions, Inc.
$350
VYNE Pharmaceuticals Inc.
$306
Celgene Corporation
$194
DERMIRA, INC.
$166
Sun Pharmaceutical Industries Inc.
$161
Mayne Pharma Inc.
$144
EPI Health, LLC
$118
Dermavant Sciences, Inc.
$112
Journey Medical Corporation
$107
MAYNE PHARMA INC.
$90
DUSA Pharmaceuticals, Inc.
$86
MAYNE PHARMA COMMERCIAL LLC
$77
E.R. Squibb & Sons, L.L.C.
$71
Lilly USA, LLC
$58
Glenmark Therapeutics Inc.
$58
SUN PHARMACEUTICAL INDUSTRIES INC.
$57
Mylan Pharmaceuticals Inc.
$57
Medimetriks Pharmaceuticals, Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$47
Promius Pharma LLC
$44
TARO PHARMACEUTICALS USA, INC.
$33
Abbott Laboratories
$27
Novartis Pharmaceuticals Corporation
$25
Aclaris Therapeutics, Inc.
$25
Encore Dermatology Inc.
$22
Arcutis Biotherapeutics, Inc.
$18
Mission Pharmacal Company
$14
Top 3 companies account for 92.3% of all-time payments
Associated products mentioned in payments ›
ADBRY · AKLIEF · ALTRENO · AMELUZ · AMPLATZER PICCOLO · AMZEEQ · ARAZLO · Absorica LD · Aczone · Ameluz · Avar · BIAFINE · BLU-U · BOTOX · BOTOX COSMETIC · BRYHALI · Bensal HP · CIBINQO · CLODERM · COSENTYX · Cabtreo · Ceracade · Clindacin ETZ · Clindamycin Phosphate and Benzoyl Peroxide · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · FINACEA · Finacea · HALOG · HUMIRA · Humira · Impoyz · JUBLIA · Klisyri · LEVULAN KERASTICK · LOCOID · Mupirocin Cream · Neo-Synalar Cream · ONEXTON · OPZELURA · ORACEA · Otezla · PICATO · QBREXZA · RETIN-A-MICRO · RHOFADE · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · Sernivo Spray · Seysara · Sitavig · Sotyktu · TALTZ · ULTRAVATE · VTAMA · Veltin · Winlevi · XEOMIN · Xeomin · Zoryve
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a dermatology specialist in Brooklyn?
Compare dermatologists in the Brooklyn area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists in nearby ZIP areas
926
County median income
$78,548
Nearest hospital to ZIP centroid (approximate)
KINGS COUNTY HOSPITAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Doyle is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Doyle experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Doyle performed 46 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Doyle receive payments from pharmaceutical companies?
Yes. Dr. Doyle received a total of $156,815 from 43 companies across 701 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doyle's costs compare to other dermatologists in Brooklyn?
Dr. Doyle's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doyle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →